comparemela.com

Latest Breaking News On - Heather savelle - Page 3 : comparemela.com

TScan Therapeutics Announces Closing of Upsized Public

WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the.

United statesNew yorkHeather savelleMaghan meyersExchange commissionTscan therapeutics incProspectus departmentTd securities united statesNeedham companyMorgan stanley coSecurities exchangeHc wainwright coGlobe newswire tscan therapeutics incMorgan stanleyNasdaq global marketSci capital

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U Louis, M D , M P H , as Chief Medical Officer

Dr. Louis brings to TScan extensive experience in cell therapy, medical affairs, and clinical and commercial developmentWALTHAM, Mass., April 08, 2024 TScan Therapeutics, Inc. , a clinical-stage.

Baylor college of medicineUnited statesChrystalu louisMelissa forstHeather savelleGavin macbeathDebora bartonSouthwestern university at georgetownProfessor at texas children cancer centerGlobe newswire tscan therapeutics incZentalis pharmaceuticalsBristol myers squibb companyTulane university school of public healthSecurities exchangeTulane university school of medicineTscan therapeutics inc

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

WALTHAM, Mass., Feb. 28, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

Heather savelleJoyce allaireGlobe newswire tscan therapeutics incTscan therapeutics incLifesci advisorsCell therapy corporate panel discussionHealth care conferenceAnnual health care conferenceMarriott copley placeSci advisors

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan’s abstract selected by the Tandem Meetings to receive a Best Abstracts Award Company to discuss the potential implications of initial data from a large prospective clinical trial assessing.

United statesShrikanta chattopadhyayMonzrm al malkiJoyce allaireDebora bartonGavin macbeathHeather savelleInternational bloodTscan therapeutics incMarrow transplant researchSecurities exchangeLifesci advisorsDepartment of hematology hematopoietic cell transplantationGlobe newswire tscan therapeutics incTandem meetingsBest abstracts

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M D , M S , as Vice President, Clinical Development

WALTHAM, Mass., Feb. 06, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

United statesUniversity of cincinnatiDebora bartonJoyce allaireHeather savelleLife edit therapeutics incTranslational researchAmgen incGlobe newswire tscan therapeutics incOnyx pharmaceuticals incEarly development at elevatebioRubius therapeutics incClinical developmentDrexel university college of medicineLifesci advisorsSecurities exchange

vimarsana © 2020. All Rights Reserved.